News

New “fast, accurate” COVID sensor developed

A COVID-19 sensor developed at Johns Hopkins University could revolutionise virus testing.

Ten-second videos predict blood cancer relapse

In a new study, 10-second videos of white blood cell motion in the skin’s microvasculature greatly improved the prediction of which stem cell and bone marrow transplant patients would have a relapse of their blood cancer.

AI potential for breast cancer screening

A major new study shows that artificial intelligence (AI) is a promising tool for breast cancer detection in screening mammography programmes.

New test predicts sepsis before blood clots

A new test predicted sepsis soon after infection in mice – well before blood clotting and organ failure – enabling early treatment and increasing survival.

Eye scanner targets neurodegenerative diseases

In a large-scale EU project, the capabilities of optical coherence tomography (OCT) and Raman spectroscopy have been combined in a novel eye scanner. Using this, it is possible to add molecular information to the visualisation of the internal structure of the eye .

“Personalised testing needed for safety”

Testing patients for genetic variations that affect how their body will respond to common medicines must be integrated fully, fairly and swiftly into the NHS.

Expanding the target range of crispr/cas systems

US researchers have created genome editing technology that allows for variations in target DNA but retains local specificity.

The Scientific Laboratory Show and Conference 2022

The Scientific Laboratory Show and Conference takes place on 18 May, hosted and organised by Scientific Laboratory Supplies.

“Diabetes in COVID-19 patients may be transitory”

Many COVID-19 patients newly diagnosed with diabetes during hospital admission may in fact have a temporary form of the disease related to the acute stress of the viral infection, it is claimed.

Under the microscope: The Gambela

This month: The Gambela

Top